疏风解毒胶囊多糖经切向流超滤分离及抗炎活性研究
本研究从疏风解毒胶囊水提物中经有机溶剂提取、醇沉、透析和切向流超滤制备多糖,并表征结构、评估抗炎活性。粗多糖得率38.72%,分离为三个组分,四种多糖在LPS刺激RAW264.7细胞及斑马鱼炎症模型中均显著降低IL-1β、IL-6、TNF-α表达与释放,提示多糖是疏风解毒胶囊主要抗炎成分之一。
要点
- 疏风解毒胶囊粗多糖得率38.72%,超滤分离为三个组分。
- 四种多糖在12.5–200 μg/mL无毒浓度下显著抑制LPS诱导的炎症因子。
- 斑马鱼模型证实多糖减少中性粒细胞迁移和炎症细胞浸润。
核心结论
- 疏风解毒胶囊多糖在LPS刺激RAW264.7细胞和斑马鱼炎症模型中显示抗炎作用。
- 研究初步证明多糖是疏风解毒胶囊主要抗炎成分之一。
研究设计与样本
- 采用有机溶剂提取、醇沉、透析和切向流超滤从疏风解毒胶囊混合水提物中制备多糖。
- 用HPGPC、IC和FT-IR表征结构,用ELISA和qRT-PCR检测细胞抗炎效应。
- 体内采用CuSO4诱导和LPS微注射斑马鱼炎症模型,进行生存分析、中性粒细胞迁移观察、H&E染色和qRT-PCR。
主要发现
- 粗多糖SFJDC-CP得率38.72%,经100 kDa、50 kDa、10 kDa膜包超滤分离为SFJDC-CP1-CP3,得率约58.19%、10.88%、30.94%。
- SFJDC-CP及其三个组分分子量分别为35.7 kDa、149.1 kDa、34.5 kDa、15.1 kDa。
- 四种多糖均由鼠李糖、阿拉伯糖、半乳糖、葡萄糖和半乳糖醛酸以不同摩尔比组成。
- 四种多糖在12.5–200 μg/mL无毒浓度下显著降低LPS刺激RAW264.7细胞中IL-1β、IL-6、TNF-α的mRNA表达和释放(P < 0.0001)。
- 多糖减少CuSO4诱导和LPS微注射斑马鱼模型中炎症细胞浸润和中性粒细胞迁移(P < 0.05或P < 0.001),并抑制LPS感染斑马鱼IL-6和TNF-α mRNA水平(P < 0.01或P < 0.001)。
关键数值与推荐
- SFJDC-CP在较低剂量下比SFJDC更有效抑制LPS刺激RAW264.7细胞TNF-α、IL-6、IL-1β分泌。
- 四种多糖非毒性浓度范围为12.5–200 μg/mL。
临床怎么用
- 为疏风解毒胶囊抗炎活性成分研究提供多糖类成分的初步证据。
- 提示可关注水提工艺中药制剂中多糖类活性成分。
局限性
- 研究为体外细胞和斑马鱼模型,尚未在哺乳动物或临床中验证。
- 多糖结构表征未涉及高级结构及构效关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Shufeng Jiedu Capsules (SFJDC) is a traditional Chinese patent medicine comprising eight traditional Chinese medicines (TCM). SFJDC is known for its anti-inflammatory and antipyretic effects and is mainly used in clinics to treat upper respiratory tract infections. Currently, studies on the active ingredients of the SFJDC all focus on small-molecule compounds. In contrast, bio-macromolecules, such as the anti-inflammatory activities of polysaccharides in SFJDC, have not been studied, and the composition of the polysaccharides in SFJDC is also unclear. AIM OF THE STUDY: This study aimed to isolate active polysaccharides from Shufeng Jiedu capsules and determine their structural properties and anti-inflammatory activities. MATERIALS AND METHODS: The polysaccharides with different molecular weights were prepared by organic solvent extraction, alcohol precipitation, dialysis, and cross-flow ultrafiltration. The structural characterization of polysaccharides was clarified by high-performance size exclusion chromatography (HPGPC), ion chromatography (IC), and Fourier transform infrared spectroscopy (FT-IR). Enzyme-linked immunosorbent assay (ELISA) and quantitative real-time PCR (qRT-PCR) assay were used to investigate the anti-inflammatory effects of polysaccharides on Lipopolysaccharides (LPS)-stimulated RAW264.7 cells. The in vivo study was employed on the CuSO4-induced and LPS-stimulated zebrafish inflammatory models, and the survival analysis, observation of neutrophil migration, hematoxylin-eosin (H&E) staining, and qRT-PCR assays were used to investigate the in vivo anti-inflammatory effect of polysaccharides. RESULTS: The crude polysaccharides SFJDC-CP were obtained from the mixed aqueous extract of SFJDC with a yield of 38.72 %. Both SFJDC and SFJDC-CP dose-dependently inhibited the secretion of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and IL-1β in LPS-stimulated RAW264.7 cells, and SFJDC-CP was more effective at a lower dosage. SFJDC-CP was further separated into three fractions, SFJDC-CP1-CP3, by cross-flow ultrafiltration apparatus with nominal molecular weight cut-offs of 100 kDa, 50 kDa, and 10 kDa membrane cassettes, and the yields were approximately 58.19 %, 10.88 %, and 30.94 %, respectively. The MWs of the SFJDC-CP and its SFJDC-CP1-CP3 were 35.7 kDa, 149.1 kDa, 34.5 kDa, and 15.1 kDa, respectively. The four polysaccharides were composed of rhamnose, arabinose, galactose, glucose, and galacturonic acid in different molar ratios. Non-toxic concentrations of the four polysaccharides ranged from 12.5 to 200 μg/mL. The four polysaccharides significantly reduced the mRNA expression levels and release of IL-1β, IL-6, and TNF-α (P < 0.0001) in LPS-stimulated RAW264.7 cells. Polysaccharides also decreased inflammatory cell infiltration and neutrophil migration (P < 0.05 or P < 0.001) in both CuSO4-induced and LPS-microinjected zebrafish inflammatory models. Additionally, they effectively inhibited the mRNA levels of IL-6 and TNF-α in LPS-infected zebrafish (P < 0.01 or P < 0.001). CONCLUSIONS: Polysaccharides isolated from Shufeng Jiedu capsules have demonstrated anti-inflammatory effects on LPS-stimulated RAW264.7 cells and zebrafish inflammatory models. This study provided preliminary evidence that polysaccharides are one of the main anti-inflammatory ingredients of Shufeng Jiedu capsules. Additionally, it may provide valuable perspectives for investigating polysaccharides in other TCM formulations, particularly those obtained through aqueous extraction methods.
引用
- Du D, Zhong H, Huang Z, et al. Polysaccharides isolated from shufeng jiedu capsules by cross-flow ultrafiltration show anti-inflammatory effects on LPS-stimulated RAW264.7 cells and zebrafish inflammatory models. J Ethnopharmacol. 2025. PMID: 40250639. doi:10.1016/j.jep.2025.119817
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。